CSC
CVS icon

Caldwell Sutter Capital’s CVS Health CVS Stock Holding History

Caldwell Sutter Capital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$147K Sell
2,044
-158
-7% -$12.2K 0.06% 254
2025
Q4 		$175K Sell
2,202
-310
-12% -$24.4K 0.07% 225
2025
Q3 		$189K Buy
2,512
+17
+0.7% +$1.17K 0.08% 217
2025
Q2 		$172K Buy
2,495
+49
+2% +$3.21K 0.08% 224
2025
Q1 		$166K Sell
2,446
-128
-5% -$7.66K 0.08% 223
2024
Q4 		$116K Buy
2,574
+160
+7% +$8.98K 0.05% 263
2024
Q3 		$152K Sell
2,414
-62
-3% -$3.62K 0.07% 235
2024
Q2 		$146K Buy
2,476
+77
+3% +$4.82K 0.07% 232
2024
Q1 		$191K Sell
2,399
-98
-4% -$7.49K 0.09% 205
2023
Q4 		$197K Buy
2,497
+249
+11% +$17.7K 0.1% 192
2023
Q3 		$157K Sell
2,248
-4,032
-64% -$286K 0.09% 206
2023
Q2 		$434K Buy
6,280
+4,329
+222% +$308K 0.23% 107
2023
Q1 		$145K Buy
1,951
+1,827
+1,473% +$153K 0.11% 162
2022
Q4 		$11.6K Buy
+124
New +$12K 0.01% 249

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Caldwell Sutter Capital's CVS Position: Q1 2026 in Review

Caldwell Sutter Capital reduced its CVS Health (CVS) stake by 7.2% in Q1 2026, selling an estimated $12.2K and leaving 2,044 shares worth $147K. The position accounts for 0.06% of the portfolio, ranked #254.

Caldwell Sutter Capital first reported a position in CVS in Q4 2022 and has held it in 14 quarters since. The position peaked at $434K in Q2 2023. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Caldwell Sutter Capital held 2,044 shares of CVS Health worth $147K as of Q1 2026.
  • Caldwell Sutter Capital sold 158 CVS Health shares in Q1 2026, an estimated $12.2K.
  • CVS Health made up 0.06% of Caldwell Sutter Capital's portfolio in Q1 2026, its #254 holding.
  • Caldwell Sutter Capital first reported a position in CVS Health in Q4 2022 and has held it in 14 quarters since.
  • Caldwell Sutter Capital's CVS Health position peaked at $434K in Q2 2023.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Caldwell Sutter Capital's 13F filing for Q1 2026, filed 6 May 2026.